Oxford track record

We are active real estate investors, developers and managers. Oxford and our platform companies manage £85 billion of best-in-class assets across four continents. Our competitive advantage is in combining global platforms and expertise with local trends and experience to create exceptional experiences and value.

 

Our mission is to help life sciences entrepreneurs grow their success, to drive scientific impact as well as social good, and to support science that improves lives around the world.

Oxford’s Life Sciences portfolio caters to all stages and needs of customers with a existing portfolio of over 5 million sq ft globally.

We offer an end-to-end mixture of R&D and GMP facilities, accommodating businesses new and established, scaling and built.

Our properties are designed to be sustainable, enhance performance, maximizing outcomes for our partners and supporting critical scientific work.

Group 7 Copy 4 Group 7 Copy 3
Pioneer Track Record
Pioneer is a respected and influential team of operators, business experts and highly strategic matchmakers.

Building businesses and ecosystems is in their DNA. Victoria House offers access to this infrastructure of expertise, enabling high-quality deal flow, early visibility of novel science, and scaled venture support to maximise growth and success.

Dr Glenn Crocker

Executive Director
  • DPhil (Oxon) Immunology
  • A Chartered accountant, was EY UK Head of Biotechnology before becoming founder CEO of BioCity Group
  • Founder, NED and investor in multiple successful life sciences companies
  • MBE for services to the biotechnology industry
Miranda Knaggs

Corporate Development Director
  • Former CEO of Stevenage Bioscience Catalyst
  • 20 years experience in bioincubators
  • Highly connected within the early-stage life sciences & healthcare industry
  • Chair of UK Bioincubators Forum
  • Expert Network manager
Dr Ayokunmi Ajetunmobi

Venture Development Director
  • PhD in Clinical Medicine
  • Has scaled venture development activity across the UK in the past six years
  • Highly connected within the early-stage life sciences & healthcare industry
  • Desktop Genetics – Head of next-gen sequencing in VC-backed start-up specializing in A.I./ML-enabled genome editing, acquired by Celixir
Toby Reid

Executive Director
  • Has managed and run life sciences focused properties and ecosystems for the last 13 years
  • Has a background in engineering and project management and business start-up & venture capital finance
  • Leads on creating the environment that helps companies scale and grow

Contact

For more information please get in touch.
Find out more Group 7 Copy 3